Needham & Company
Ami Fadia is a highly experienced Managing Director and Senior Biotech Equity Research Analyst with a strong background in covering stocks of companies focused on pain, women's health, anti-infective, and generics/biosimilars. Ami has held various key positions in reputable companies such as SVB Leerink, UBS, and Banc of America Investments. With a solid educational background in finance, analytical consulting, accounting, taxation, and auditing, Ami brings a wealth of knowledge and expertise to the industry.